Nanjing Hicin Pharmaceutical Co., Ltd. (SZSE: 300584)
Health Care · Pharmaceuticals · CN
CN¥31.18
+3.11% today · -51.1% 1Y
Nanjing Hicin Pharmaceutical Co., Ltd. (SZSE: 300584) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $557.80M and employs 553 people.
Over the last twelve months the share price has lost 51.1%, trading between 27.68 and 73.40.
Tweenvest scores Nanjing Hicin Pharmaceutical Co., Ltd. across four factors: quality 59/100, value 41/100, growth 55/100, dividend 40/100. Its strongest factor is quality.
300584 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $557.80M
- Revenue (TTM)
- $106.97M
- P/E
- 83.21
- EPS
- 0.37
- Dividend yield
- 0.32%
- Beta (5Y)
- 0.07
- 52-week high
- CN¥73.40
- 52-week low
- CN¥27.68
- Avg volume (3M)
- —
- Shares outstanding
- 120.00M
- Employees
- 553
- Next earnings
- —
About Nanjing Hicin Pharmaceutical Co., Ltd.
Nanjing Hicin Pharmaceutical Co., Ltd. (NHPC), established in 2003 and headquartered in Nanjing, China, operates as a comprehensive enterprise specializing in the research, development, production, marketing, and distribution of pharmaceutical preparations and synthetic chemicals within China. The company boasts a diverse product portfolio, addressing various therapeutic areas such as antivirals, antibiotics, endocrine regulators, gastrointestinal treatments, orthopedic medications, cardiovascular and cerebrovascular drugs, and immunomodulatory agents. Beyond its core pharmaceutical activities, NHPC also provides technology transfer services. On an international scale, Nanjing Hicin Pharmaceutical Co., Ltd. is a supplier of Active Pharmaceutical Ingredients (APIs). Its export offerings specifically include injectable forms of omeprazole sodium and cefepime hydrochloride, along with lansoprazole tablets, which reach markets across South Asia, South America, and Europe.
- ISIN
- CNE100002F44
- Founded
- 2003
- Listed since
- Jan 12, 2017
- Exchange
- Shenzhen Stock Exchange
- Currency
- CNY
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| FDC LimitedBSE: 531599 | $567.41M | Rs335.55 | -1.61% |
| Kingchem (Liaoning) Life Science Co., Ltd.SZSE: 301509 | $561.13M | CN¥31.25 | +0.19% |
| Huaren Pharmaceutical Co., Ltd.SZSE: 300110 | $558.70M | CN¥3.17 | -8.12% |
| GlaxoSmithKline S.A.ECASE: BIOC | $558.53M | EGP350.11 | +36.94% |
| Zhuhai Rundu Pharmaceutical Co., Ltd.SZSE: 002923 | $550.68M | CN¥11.03 | +1.66% |
| Phathom Pharmaceuticals, Inc.NasdaqGS: PHAT | $549.66M | $7.13 | +3.03% |
| Clarity Pharmaceuticals LtdASX: CU6 | $544.53M | AU$2.10 | -0.47% |
| Komipharm International Co., Ltd.KOSDAQ: A041960 | $530.71M | ₩9,880.00 | +0.30% |
Figures last refreshed Oct 4, 2026.